Cargando…
Bioinformatics analysis of gene expression profiles to identify causal genes in luminal B2 breast cancer
Patients with the luminal B subtype of breast cancer exhibit a poor prognosis, high metastatic risk and high incidence of chemotherapy resistance. Luminal B breast cancer is sub-classified into B1 and B2. The pathophysiological mechanism of luminal B2 breast cancer (LB2BC) progression has yet to be...
Autores principales: | Wang, Jinguang, Du, Qi, Li, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727610/ https://www.ncbi.nlm.nih.gov/pubmed/29250180 http://dx.doi.org/10.3892/ol.2017.7256 |
Ejemplares similares
-
Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling
por: Cornen, Stéphanie, et al.
Publicado: (2014) -
Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer
por: Loi, Sherene, et al.
Publicado: (2009) -
The molecular profile of luminal B breast cancer
por: Creighton, Chad J
Publicado: (2012) -
Immune gene expression profiling reveals heterogeneity in luminal breast tumors
por: Zhu, Bin, et al.
Publicado: (2019) -
Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis
por: Jia, Rong, et al.
Publicado: (2020)